Most drugs have not been adequately studied in children, but, legislation in the US, the Best Pharmaceuticals for Children Act of 2001 and the Pediatric Research Equity Act of 2003 (both made permanent in 2012 [3]) now provide the statutory and regulatory authority to incentivize and require therapeutic trials in children.